Tight glucose control in critically ill adults [1]

JAMA

Volumn 300, Issue 23, 2008, Pages 2725-

  Hermans, Greet ^a   Schetz, Miet ^a   Van Den Berghe, Greet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

CLINICAL TRIAL; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE UNIT; ISCHEMIA; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

EID: 58049216672     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2008.815     Document Type: Letter

References (4)

1. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300(8):933-944.
2. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359-1367.
3. van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-461.
4. Higgins JP, Green S, eds. Cochrane handbook for systematic reviews of interventions: version 5.0.0 [updated February 2008]. The Cochrane Collaboration. http://www.cochrane-handbook.org. Accessed November 20, 2008.